Pharmaceutical

Sun Pharma launches brand film with Royal Challengers B...

Campaign highlights association as principal sponsor and health partner during ...

Travere Therapeutics gains FDA approval for sparsentan ...

The approval makes Filspari the first and only FDA-approved medicine to treat FS...

MSD, Daiichi Sankyo’s ifinatamab deruxtecan receives FD...

The treatment targets adult patients with ES-SCLC who have experienced disease p...

Novo Nordisk announces partnership with OpenAI

Partnership applies AI to drug discovery and operations across Novo Nordisk and...

Aragen launches ChemiSHE, India’s first women-led chemi...

Announces strategic diversity initiative to add 800 - 1,000 women employees acr...

India Pharma 2026 highlights policy push, innovation dr...

India is poised to lead the global pharma landscape with a focus on biosimilars...

Telix and Regeneron to co-develop radiopharmaceutical t...

Telix and Regeneron Pharmaceuticals have entered a partnership for the developme...

FDA issues complete response letter to Replimune’s RP1 ...

The decision affects Replimune’s lead product candidate, which is based on a gen...

Pharma firms accelerate regional capacity building to s...

GlobalData highlights shift towards localised manufacturing, inventory security...

Merck signs MoU with MAHE to expand healthcare R&D tale...

Catalyst training programme launched to link academic learning with industry re...

India brings together a rare and powerful combination o...

Dr Kshitij Panse,Chief Operation Officer,GATINN by Servier,in an interaction wi...

The GLP-1 revolution

A new class of drugs is reshaping global health,but India’s generics wave could...

Foundayo, Lilly’s new oral GLP-1 pill for weight loss, ...

Eli Lilly and Company announced that Foundayo (orforglipron) is now available t...

Roche and C4 Therapeutics to advance degrader-antibody ...

According to the joint research plan, the companies will partner on two programm...

Gan & Lee and JW Pharmaceutical agree on bofanglutide c...

Bofanglutide is a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) d...

EverSea Medicines to acquire Hasten Biopharmaceuticals

The acquisition aims to enhance Everest Medicines’ presence and commercial capab...